2026 Q2 Portfolio Activity
In 2026 Q2, GILEAD SCIENCES, INC. maintained a portfolio of 6 distinct positions. They heavily accumulated shares in Assembly Biosciences Inc., increasing the position by 10.5%. Conversely, GILEAD SCIENCES, INC. completely exited their position in Arcellx Inc.
Position History
hover any row below to update
Loading…
Total Positions
6
Quarter
2026 Q2
Top Holding
RCUS (58.8%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-6 of 6
GILEAD SCIENCES, INC. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RCUS
Arcus Bioscienc...
|
Healthcare | 58.76% | 32.05% |
#1
1
Prev: #2
|
7.0 |
—
|
no change | no change |
P
S
|
31,424,760 | $968,825,351 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-03 | |||
|
GLPG
Lakefront Bioth...
|
Healthcare | 30.34% | 23.67% |
#2
1
Prev: #3
|
6.5 |
—
|
no change | no change |
P
S
|
16,707,477 | $500,157,715 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-03 | |||
|
ASMB
Assembly Biosci...
|
Healthcare | 8.30% | 5.90% |
#3
1
Prev: #4
|
6.3 |
—
|
471,698 | 10.5% |
P
S
|
4,977,089 | $136,770,406 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-03 | |||
|
KYTX
Kyverna Therape...
|
Healthcare | 2.23% | 1.68% |
#4
1
Prev: #5
|
2.4 |
—
|
no change | no change |
P
S
|
4,126,119 | $36,763,720 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-03 | |||
|
XLO
Xilio Therapeut...
|
Healthcare | 0.38% | 0.26% |
#5
1
Prev: #6
|
1.7 |
—
|
no change | no change |
P
S
|
650,389 | $6,230,727 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-03 | |||
|
ACLX
Arcellx Inc
|
Healthcare | 0.00% | 36.44% |
Sold All 😨
(Was: #1) |
0.0 |
—
|
-6,720,803 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-03 |
Showing 1-6 of 6 holdings